Anavex Life Sciences Corp. Encouraged By Scientific Data Confirming...
Anavex Life Sciences Corp. , a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, diseases of the central nervous system and various types of cancer, today announced the findings of a research report published in the current issue of peer-reviewed scientific journal Neuroscience Letters.
Trending on the Topix Network
Sun Mar 09, 2014
The Victoria Advocate
Victorians unite to fight ALS
For more information about the people with ALS support group, or PALS, contact the Rev.
Wed Mar 05, 2014
Cytokinetics: Small Cap Biotech Investment And Catalyst Trade In Focus
Today, we are going to focus on a developmental biotech with significant 2014 catalysts that we feel could make a positive impact on its stock price.
Mon Mar 03, 2014
Adeno-associated Virus-mediated Delivery of a Recombinant...
Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis 1Research Centre of Institut universitaire en santé mentale de Québec, Québec, Québec, Canada; Correspondence: Jean-Pierre Julien, Research ... (more)
Experimental stroke drug also shows promise for people with Lou Gehrig's disease
New Keck School of Medicine of USC research finds vascular damage in mice with ALS contributes to early development of the neurodegenerative disease, while repairing damage delays disease progression A fluorescent image shows cells of the neurovascular unit in the mouse spinal cord, which consists of motor neurons and blood vessels containing ... (more)
Thu Feb 27, 2014
SOD1 aggregation and ALS: role of metallation states and disulfide status.
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
San Marino Tribune
High Calorie Diet May Slow Lou Gehriga s Disease
A diet rich in calories and carbohydrates may slow progression of the lethal, degenerative Lou Gehrig's disease, according to a small-scale study reported in The Lancet on Friday.
WTKA-AM Ann Arbor
Death by Header? 1st Soccer Player Found with Concussion Disease
The first soccer player to be diagnosed with Chronic Traumatic Encephalopathy has drawn attention to the possibility that a sport formerly thought of as "safer" than football or hockey can still result degenerative effects on the neurological system.
Wed Feb 19, 2014
Dodgeball tournament to benefit Lou Gehrig's research
Naperville Central High School freshmen Delaney Gibbons and Taylor Morrissey are expecting a sell-out crowd Feb. 28 during the third Dodgin' 4 Lou Gehrig's Disease Tournament at Naperville North High School.
Tue Feb 18, 2014
Neuralstem Phase 1 Data Gives Hope In ALS
Data from the Phase 1 trial of Neuralstem's NSI-566 in Amyotrophic Lateral Sclerosis patients was presented at the 2013 American Neurology Association Meeting in October 2013 and is being published in the Annals of Neurology .
Tue Feb 11, 2014
Global Amyotrophic Lateral Sclerosis Market 2014-2018
Reportstack, provider of premium market research reports announces the addition of Global Amyotrophic Lateral Sclerosis Market 2014-2018 market report to its offering Analysts forecast the Global Amyotrophic Lateral Sclerosis Drugs Market to grow at a CAGR of 5.39 percent over the period 2013-2018.